HealthQuill Chikungunya
Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals older than 18 years of age and who are at increased risk of exposure to the disease.
Drugs Health Pharma

Valneva’s chikungunya jab gets FDA nod, first such for disease

HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals.

Read More
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
https://healthquill.com/healthcare-workers-global-shortage-wef/
Health Medical Pharma

Stop attacks on healthcare workers, WHO tells Sudan’s warring factions

HQ Team April 19, 2023: The WHO called on Sudan’s warring factions to refrain from attacks on healthcare personnel, as about 270 people.

Read More
Dengue viral infection has increased from 505,430 cases in 2000 to 5.2 million in 2019, and its spread among humans is increasing globally, the WHO stated
Climate Health Pharma

Dengue viral infections on the rise globally: WHO

HQ Team April 6, 2023: Dengue viral infection has increased from 505,430 cases in 2000 to 5.2 million in 2019, and its spread.

Read More
X